Tripod Nano Technology

Tripod Nano Technology is a Taiwanese biotechnology company specializing in the development of gold nanoparticle-based platforms for therapeutic and diagnostic applications. Spun off from the Tripod Group, the company leverages its proprietary Nano-Gold platform to enable precise conjugation of antibodies and drugs, creating stable and targeted delivery systems. Their primary research focus is in oncology, where they are developing gold-based antibody-drug conjugates (ADCs) to treat HER2-positive cancers. Beyond therapeutics, the company produces high-sensitivity rapid diagnostic kits for infectious diseases, utilizing the unique optical properties of nano-gold. Their technology aims to improve drug efficacy and diagnostic accuracy through advanced surface modification and green synthesis techniques.